HIV variants that have mutated to escape T-cell immune responses dominate the latent viral reservoir in most patients on antiretroviral therapy. This finding will need to guide therapeutic approaches targeting reactivated virus. See Letter p.381
© 2001-2025 Fundación Dialnet · Todos los derechos reservados